What it is
Semaglutide acts on GLP-1 receptors involved in appetite and blood-sugar regulation. This page does not recommend a product or provide dosing instructions.
Treatment information
Semaglutide: an educational overview
Semaglutide is a GLP-1 receptor agonist. Certain semaglutide products are FDA-approved for specific indications, but product, formulation, dose, access, and clinical appropriateness are individual decisions.
What review covers
A clinician considers medical history, current medications, allergies, contraindications, pregnancy status, symptoms, and other factors before discussing treatment.
What to discuss
Ask about serious and common risks, warning symptoms, interactions, monitoring, alternatives, expected follow-up, and what to do if side effects occur.
Your next step
Start with a secure health assessment
A licensed clinician must independently review your information before any treatment plan or prescription can be offered.
Begin assessmentIf a compounded option is ever offered, it is not FDA-approved and must not be described as a generic equivalent or as identical to a brand-name drug. Availability and appropriateness depend on the prescribing clinician and dispensing pharmacy.